MM

Mahindra Makhija

Head Of Translational Research - Exscalate Drug Discovery And Development at DOMPE

Mahindra Makhija is an accomplished professional in the pharmaceutical industry, currently serving as the Head of Translational Research at Dompé since September 2023, where responsibilities include leading the translation of internal programs and evaluating external opportunities in rare and non-rare diseases. Previously, Makhija held various leadership roles at Takeda from 2007 to 2023, including Director of Translational and External Innovation Lead, focusing on preclinical and clinical translation in the rare disease space. Makhija has also served as Associate Director at Eurofins, overseeing strategic alliances and research collaborations for CNS, autoimmune, and metabolic disorders, and held positions with ALTANA AG and the Western Australian Biomedical Research Institute. Educationally, Makhija holds a PhD and a Master's degree in Medicinal and Pharmaceutical Chemistry from the University Department of Chemical Technology and Curtin University.

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


DOMPE

2 followers

DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personalhygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory.Founded in 1940, Dompe is headquartered in Milan, Italy.


Headquarters

Milan, Italy

Employees

501-1,000

Links